Dra. María Blasco: oncóloga especializada en alargar la vida

Doctora Honoris Causa María Antonia Blasco Marhuenda (Verdegás, Alicante, Alicante, 1965), conocida como María Blasco (María Blasco Marhuenda en las redes, aunque ella firma como María A. Blasco en su curriculum vitae), es una científica española especializada en los telómeros y la telomerasa. ​Desde el 22 de junio de 2011 dirige en España el Centro Nacional de Investigaciones Oncológicas (CNIO).

Artículos de opinión

Realidad y ficción contra el machismo: 
'Lean in' y 'Borgen' 
http://www.huffingtonpost.es/maria-a-blasco/lean-in-y-borgen-machismo-mujeres-directivas_b_3377285.html 

Desigualdad de género; ¿a qué estamos esperando? 
http://www.huffingtonpost.es/maria-a-blasco/desigualdad-de-genero-a-q_b_2827320.html 

(Foto: Dra. María A. Blasco, foto realizada con derechos CC BY 2.0, de Cristina Cifuentes, 2015, Madrid)

Enlaces externos

Telomerasa:  la enzima de la eterna juventud (Noticias TV1 14 de mayo de 2014)
http://www.rtve.es/alacarta/videos/telediario/telomerasa-enzima-eterna-juventud/2564480/ La telomerasa

Camino a la inmortalidad, documental RTVE, 52 mt, con la participación de María Blasco 

https://web.archive.org/web/20100621135215/http://www.rtve.es/mediateca/videos/20100125/imprescindibles-camino-a-inmortalidad/691972.shtml

Debate del vídeo anterior: http://www.rtve.es/alacarta/videos/los-debates-de-culturales/debates-culturales-29-05-10/787920

EMBO - European Molecular Biology Organization

http://www.embo.org/

 Life Length 

http://www.lifelength.com/esp/index.html

Artículos de prensa

¿Quiere saber cuánto le queda?. Un test desarrollado por la científica María Blasco se postula para medir la 'edad biológica', 31/7/2011, El País

http://www.elpais.com/articulo/reportajes/Quiere/saber/le/queda/elpepusocdmg/20110731elpdmgrep_6/Tes

Prueban con éxito la primera terapia génica contra el envejecimiento (ABC, 15 de mayo de 2012)

http://www.abc.es/20120515/sociedad/abci-terapia-genica-envejecimiento-201205142217.html

Saber más:  

https://11defebrero.org/2017/01/15/maria-blasco/#more-808

EL Mundo: "una de las alumnas aventajadas de dos de las Premio Nobel de Medicina 2009, C. Greider y L. Blackburn."

"El secreto para llegar a todo (o casi)"
 https://elpais.com/elpais/2012/04/23/mujeres/1335166963_133516.html

"Hemos conseguido retrasar las enfermedades"
http://www.quo.es/ciencia/seleccion-espanola-de-ciencia/maria-blasco-hemos-conseguido-retrasar-las-enfermedades

Curar la fibrosis pulmorar
http://www.diarioinformacion.com/cultura/2018/01/30/cientificos-liderados-maria-blasco-curan/1983152.html

Al frente del Centro Nacional de Investigaciones Oncológicas (CNIO)
https://www.20minutos.es/noticia/1089856/0/blasco/investigacion/oncologica/ 

Currículo en inglés https://www.cnio.es/es/grupos/plantillas/curriculum.asp?pag=39 

Biosketch: María A. Blasco

Maria A. Blasco (Alicante, 1965) obtained her PhD in 1993 for her research at the Centro de Biología Molecular "Severo Ochoa" under the supervision of M. Salas. That same year, Blasco joined the Cold Spring Harbor Laboratory in New York (USA) as a Postdoctoral Fellow under the leadership of C. W. Greider. In 1997 she returned to Spain to start her own research Group at the Centro Nacional de Biotecnología in Madrid. She joined the CNIO in 2003 as Director of the Molecular Oncology Programme and Leader of the Telomeres and Telomerase Group. In 2005 she was also assigned as Vice-Director of Basic Research and in 2011 she was appointed as CNIO Director.

Her major research achievements include: (1) Isolation of the core components of mouse telomerase and generation of the first knockout mouse for telomerase; (2) Generation of the first mouse with increased telomerase expression in adult tissues; (3) The finding that mammalian telomeres and subtelomeres have epigenetic marks characteristic of constitutive heterochromatin; (4) Discovery of telomeric RNAs, which are potent telomerase-inhibitors whose expression is altered in cancer; (5) Demonstration that telomerase activity and telomere length determine the regenerative capacity of adult stem cells; (6) Identification of the longest telomeres as a universal feature of adult stem cell niches; (7) The finding that telomerase overexpression in the context of cancer resistant-mice improves organismal fitness, produces a systemic delay in ageing and an extension in median life-span; (8) Discovery that telomeres rejuvenate after nuclear reprogramming; (9) Identification of the molecular mechanisms by which short telomeres/DNA damage limit nuclear reprogramming of defective cells; (10) Discovery that telomeric protein TRF1 can act as both a tumour suppressor and as a factor in ageing prevention.

Blasco has received the Josef Steiner Cancer Research, Rey Jaime I, Körber European Science, Alberto Sols and Fundación Lilly Preclinical Research, Awards. She has also been the recipient of the Spanish National "Santiago Ramón y Cajal" Research Award in Biology (2010). Blasco has also been awarded the EMBO Gold Medal and has served on its Council since 2008.

Learn More: http://www.ae-info.org/ae/Member/Blasco_Maria